Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01427660 · ClinicalTrials.gov registry record · NA

iDecide.Decido: Diabetes Medication Decision Support Study

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
190
Enrollment target

NCT01427660 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 190 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01427660, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
190 participants
Enrollment target

Study Summary

Two of AHRQ 's consumer-focused guides, "Pills for Type 2 Diabetes" and "Premixed Insulin for Type 2 Diabetes" could be of great use to underserved ethnic and racial minority adults. The presentation of content and delivery mechanisms of these Guides, however, needs to be modified to increase their use and impact among these difficult-to-reach populations. To achieve this goal, a long-standing collaboration among African American and Latino community organizations, health care centers and systems, public health organizations, and academics (the REACH Detroit Partnership) is joining with leading experts in the development of personally and culturally tailored health decision aids (University of Michigan's Center for Health Communications Research \[CHCR\] and Center for Behavioral and Decision Sciences in Medicine \[CBDSM\]). The investigators will develop and evaluate a computer tailored online diabetes medication decision aid that will enable community health workers (CHWs) to provide personalized patient education materials to underserved diabetic African American and Latino adults in Detroit, Michigan.

Interventions

  • BEHAVIORAL Community Health Worker Diabetes Education: Print media
  • BEHAVIORAL CHW Diabetes Education: tailored web site

Trial Details

FieldValue
Enrollment Target 190 participants
Start Date 2011-09
Est. Completion 2013-10
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT01427660

The ClinicalTrials.gov registry entry for NCT01427660 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Community Health Worker Diabetes Education: Print media is the first listed.

NCT01427660 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01427660 about?

NCT01427660 is a clinical study titled "iDecide.Decido: Diabetes Medication Decision Support Study". Two of AHRQ 's consumer-focused guides, "Pills for Type 2 Diabetes" and "Premixed Insulin for Type 2 Diabetes" could be of great use to underserved ethnic and racial minority adults. The presentation of content and delivery mechanisms of these Guides, however, needs to be modified to increase their ...

What is the current status of trial NCT01427660?

This trial is currently completed. It is a NA study. The enrollment target is 190 participants. The study started on 2011-09. Estimated completion is 2013-10.

What interventions are being tested in trial NCT01427660?

The interventions under investigation include: Community Health Worker Diabetes Education: Print media (BEHAVIORAL), CHW Diabetes Education: tailored web site (BEHAVIORAL).

Who is sponsoring clinical trial NCT01427660?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.